Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Oric Pharmaceuticals (ORIC) Return on Assets (2020 - 2026)

Oric Pharmaceuticals filings provide 7 years of Return on Assets readings, the most recent being 0.0% for Q1 2026.

  • Quarterly Return on Assets changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Assets hit 0.0% in Q1 2026 for Oric Pharmaceuticals, down from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q1 2022 and bottomed at 0.01% in Q1 2025.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.0% recorded in 2022.
  • Peak annual rise in Return on Assets hit 0bps in 2022, while the deepest fall reached 0bps in 2022.
  • Oric Pharmaceuticals' Return on Assets stood at 0.0% in 2022, then decreased by -11bps to 0.0% in 2023, then decreased by -20bps to 0.0% in 2024, then skyrocketed by 31bps to 0.0% in 2025, then decreased by -4bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Return on Assets are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).